TripleBar Bio, Inc.

EMERYVILLE, CA · Founded 2019 · Biotech · Private

AI platform for genomic design automation that uses evolutionary algorithms to enable protein and organism design

Claim this profile

Follows are private to you and power your alerts

Updated · triplebar.com

Sector
Biotech
Headquarters
EMERYVILLE, CA
Founded
2019
Latest Form D
$19.8M, Oct 2023
Total capital
$19.8M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$19.8M
1 Form D · last Oct 2023
36 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
6 pending · first 2024
Rank in peer group#8 of 55

Capital timeline

2023FEDERAL ↑EQUITY ↓Cumulative $19.8M1st Form D$19.8M
2023FEDERAL ↑EQUITY ↓Cumulative $19.8M1st Form D$19.8M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$19.8M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 55 peers

Line = median

Biotech · Software

  • Granted patents#8 · top 15%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • David FriedbergDirectorNamed in SEC Form D filings
  • Howard LevinDirectorNamed in SEC Form D filings
  • Maria ChoExecutive Officer, DirectorNamed in SEC Form D filings
  • Rose WardleDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 8
  • PendingMultiparametric Discovery And Optimization PlatformUSPTOApplication 18864951
  • PendingMultiparametric Discovery And Optimization PlatformUSPTOApplication 18617186
  • GrantedMultiparametric Discovery And Optimization PlatformUSPTOUS 11,972,840
Show all 8 patent records
  • Multiparametric Discovery And Optimization PlatformSep 18, 2025 · Application 18864951Pending
  • Multiparametric Discovery And Optimization PlatformFeb 20, 2025 · Application 18617186Pending
  • Multiparametric Discovery And Optimization PlatformApr 30, 2024 · US 11,972,840Granted
  • Multiparametric Discovery And Optimization PlatformMar 5, 2024 · US 11,923,045Granted
  • Multiparametric Discovery And Optimization PlatformApplication PCTUS2023067263Pending
  • Multiparametric Discovery And Optimization PlatformApplication 63343966Pending
  • Multiparametric Discovery And Optimization PlatformApplication PCTUS2021059275Pending
  • Multiparametric Discovery And Optimization PlatformApplication 63113571Pending

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .